Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 342

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 342
---
 Ben Hwang,
who reviews financial information presented on a consolidated net loss basis as reported on the consolidated condensed statement of operations
and comprehensive loss in order to make decisions about allocating resources and assessing performance for the entire Company. The CODM
also utilizes the Company’s long-range plan, which includes product development roadmaps and long-range financial models, as a key
input to resource allocation. The CODM function approves of key operating and strategic decisions. The CODM function views the Company’s
operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly
provided with the following significant segment expenses. Significant expenses include research and development and general and administrative
expenses, which are each separately presented in the Company’s consolidated condensed statements of operations and comprehensive
loss. The CODM reviews significant expenses within both the research and development and the general and administrative categories. Other
segment items within net loss include interest income, interest expense and loss on change in fair value of related party loan. See the
consolidated condensed financial statements for other financial information regarding the Company’s operating segment.

|                                                                                 |     | Three Months Ended 
 June 30,           |   2025 |   |     |   |   2024 |   |
|:--------------------------------------------------------------------------------|:----|:-------------------|-------:|:--|:----|:--|-------:|:--|
| Government grant revenue                                                        |     | $                  |      — |   |     | $ |     25 |   |
| Operating expenses:                                                             |     |                    |        |   |     |   |        |   |
| Research personnel compensation costs, including stock-based                    
 compensation                                                                    |     |                    |    320 |   |     |   |    385 |   |
| CRO and regulatory costs                                                        |     |                    |      — |   |     |   |      — |   |
| Administrative personnel compensation costs, including stock-based compensation |     |                    |    401 |   |     |   |    350 |   |
| Rent and office costs                                                           |     |                    |    118 |   |     |   |     80 |   |
| Legal and accounting costs                                                      |     |                    |    110 |   |     |   |    179 |   |
| Other expenses(1)                                                               |     |                    |     54 |   |     |   |      7 |   |
| Total